Corinna Odar

Corinna Odar is a dedicated scientist with extensive experience in biotechnology and biopharmaceuticals. Currently serving as a Scientist at acib GmbH since August 2022, Corinna has previously held roles such as Postdoctoral Research Scientist at Medizinische Universität Graz, focusing on in-situ hybridization for cancer markers. Additional experience includes a position as a Process Specialist at Sandoz, specializing in biosimilar production, and a notable tenure at acib GmbH working on ginsenoside production and enzyme engineering. Corinna's research journey includes contributions to antimicrobial peptide expression and training as a visiting scholar at UC Berkeley, alongside foundational experiences in organic chemistry at Syracuse University and research training in Spain. Corinna Odar holds a Doctor of Philosophy (PhD) in Biotechnology from Technische Universität Graz.